# VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) Page: https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo Text version: https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo.md Podcast: [PsychRounds: The Psychiatry Podcast](https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703) Published: 2026-03-21T17:57:26+00:00 Episode link: https://podcasters.spotify.com/pod/show/psychrounds/episodes/VMAT2-Inhibitors-Valbenazine-Ingrezza-and-Deutetrabenazine-Austedo-e3g8odb Audio file: https://anchor.fm/s/eb936048/podcast/play/116727659/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-2-11%2F419751627-44100-2-e2a85ebd5c645.m4a Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo Duration seconds: 1039 ## Resource Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/ ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.